Qiagen NV (NYSE:QGEN) currently has a daily average trading volume of 1.35M but it saw 1008441 shares traded in last market. With a market cap of 9.24B USD, the company’s current market price of $42.75 came rising about 0.28 while comparing to the previous closing price of $42.63. In past 52 weeks, the stock remained buoying in the range of price level as high as $47.92 and as low as $37.63. In the recent trading on the day, stock has struck highest price mark of $42.48 while lowest mark touched by it was $43.19.
Taking a look at 20-day trading activity of Qiagen NV (QGEN) gives us an average price of $41.27, while its current price level is -10.79% below from 52-week high level whereas it is 13.61% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $40.10 while that of 200 days or SMA-200 reads an average of $43.98. A closer look into the stock’s movement over the week reveals that its volatility is standing at 1.67% during that period while stretching the period over a month that increases to 3.14%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 58.32 which implies that the stock is in neutral territory.
Robert W. Baird downgraded its recommendation for the stock as a “Neutral” from “Outperform” on February 19, 2025 while assigning a price target range of $52-$42. Morgan Stanley also issued its recommendations for the stock as it downgraded the price target for the stock is $48.
Over the week, QGEN’s stock price is moving 1.02% up while it is 6.48% when we observe its performance for the past one month. Year-to-date it is -3.98% down and over the past year, the stock is showing an upside performance of 2.66%.
Currently, Qiagen NV’s total number of outstanding shares is 216.12M with 1.88% of that held by the insiders while 63.53% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 1.67% and return on equity (ROE) at 2.27%. It has a price to earnings ratio (P/E ratio) of 115.07 while having a 17.25 of forward P/E ratio. Stock’s beta reads 0.67. Stock has a price to book (P/B) ratio of 2.59 while price to sale or P/S ratio amounts to 4.67. Its return on asset (ROA) is 1.42% on average.
